FundedIQ
Biotechnology

GelSana Therapeutics: Funding, Investors & Team (Oct 2026)

GelSana Therapeutics develops new products to heal wounds faster. The hydrogels accelerate wound closure with a moist, protected, anti-inflammatory environment.

gelsanatherapeutics.com LinkedIn Aurora, United States 1-10 employees
Total raised
$300k
Rounds
1
Latest
Grant
Nov 2021

GelSana Therapeutics has raised $300k across 1 funding round on record, the most recent a Grant of $300k announced in Nov 2021.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

GelSana Therapeutics Company Profile and Key Stats

Total funding raised
$300k
across 1 round on record
Funding rounds on record
1
Latest funding round
Grant
$300k in Nov 2021
Employees
1-10
reported band
Headquarters
Aurora, United States

Latest funding round on record: Nov 2021.

GelSana Therapeutics Funding Rounds

Date
Round
Amount
Grant
$300k

GelSana Therapeutics Founders and Leadership Team

Name
Role
Contact
Melissa Krebs
CEO
—

No contact details are on record for this team yet.

GelSana Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
1,065
—

GelSana Therapeutics' latest round of $300k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like GelSana Therapeutics in Biotechnology and Aurora

Companies Similar to GelSana Therapeutics

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

GelSana Therapeutics Funding FAQs

What does GelSana Therapeutics do?

GelSana Therapeutics develops new products to heal wounds faster. The hydrogels accelerate wound closure with a moist, protected, anti-inflammatory environment.

How much funding has GelSana Therapeutics raised?

GelSana Therapeutics has raised $300k across 1 round on record. The most recent is a Grant of $300k announced in Nov 2021.

When did GelSana Therapeutics last raise funding?

GelSana Therapeutics' most recent funding round on record is a Grant of $300k, announced in Nov 2021.

Who is the CEO of GelSana Therapeutics?

Melissa Krebs is listed as CEO at GelSana Therapeutics.

Where is GelSana Therapeutics headquartered?

GelSana Therapeutics is based in Aurora, Colorado, United States.

How many employees does GelSana Therapeutics have?

GelSana Therapeutics is in the 1-10 employee band.

How does GelSana Therapeutics' funding compare to other Biotechnology startups?

GelSana Therapeutics' latest round of $300k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's GelSana Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GelSana Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.